Leflunomide therapy in kidney transplantation: ready for prime time?
Mannon
Roslyn B
RB
D000998:Antiviral Agents / Q000009:adverse effects*; D001739:BK Virus / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000517:prevention & control* / Q000821:virology; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007555:Isoxazoles / Q000009:adverse effects*; D007668:Kidney / Q000187:drug effects* / Q000473:pathology / Q000601:surgery / Q000821:virology; D016030:Kidney Transplantation; D000077339:Leflunomide; D027601:Polyomavirus Infections / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D013927:Thrombosis / Q000139:chemically induced; D013997:Time Factors; D019562:Viral Load
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide